Joe Loy is a healthcare executive and CEO of Zetagen Therapeutics. His experience includes securing more than $25 million in funding for FDA-regulated innovations in regenerative medicine. His work includes 65 patents across 36 countries and two FDA Breakthrough Device designations. As the leader of a clinical-stage healthcare company, Joe brings experience in financing, intellectual property, and advancing FDA-regulated innovation.
